REPLACEMENT OF HIGH DOSE COMBINATION CHEMOTHERAPY WITH BLINATUMOMAB IN NEWLY DIAGNOSED PEDIATRIC HIGH-RISK B-CELL ALL IMPROVES EFFICACY AND SAFETY IN THE RANDOMIZED PHASE 3 AIEOP-BFM ALL 2017 TRIAL

EHA Library, Martin Schrappe, 4206657

A BIMODAL FRAMEWORK FOR RELIABLE AND ACCESSIBLE ACUTE LEUKEMIA MACHINE LEARNING CLASSIFICATION USING GENE EXPRESSION AND DNA METHYLATION DATA

EHA Library, Mariya Lysenkova Wiklander, 4206888

NANOPORE-BASED GENOMIC AND EPIGENOMIC PROFILING FOR PEDIATRIC HEMATOLOGIC MALIGNANCIES USING TARGETED ADAPTIVE SAMPLING LONG-READ SEQUENCING: INTERIM REPORT OF THE JCCG-WGS STUDY

EHA Library, Shota Kato, 4206886

ANTIBODY-BASED IMMUNOTHERAPY VERSUS CELLULAR THERAPY AS BRIDGING TO ALLOGENEIC STEM CELL TRANSPLANTATION IN RELAPSED/REFRACTORY OR MRD-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Ao-ran Zhang, 4206665

BRANCHED-CHAIN AMINO ACID BIOAVAILABILITY DURING CD19 CAR T-CELL EXPANSION ASSOCIATES WITH FAVORABLE T-CELL STATES AND CLINICAL RESPONSE IN LBCL

EHA Library, Sylvain Lamure, 4206838

MULTIPLEX PRIME EDITING ENABLES SAFE, DRUG-CONTROLLABLE, AND IMMUNOSUPPRESSION-RESISTANT T-CELL THERAPIES

EHA Library, Thomas Lew, 4206834

REFINING PROGNOSTIC STRATIFICATION FOR SAML POST-ALLO-HSCT: VALIDATION OF ELN 2022 AND PREDOMINANT ROLE OF MDS-RELATED CYTOGENETICS.

EHA Library, Nan Yang, 4206825

TRIM5 DRIVES T CELL PATHOGENICITY IN GRAFT-VERSUS-HOST DISEASE THROUGH SLC25A35 UBIQUITINATION

EHA Library, Qiao Cheng, 4206817

INTEGRATED GENOMIC AND TRANSCRIPTOMIC ANALYSES REVEAL BIOLOGICAL HETEROGENEITY OF ACCELERATED-PHASE CHRONIC MYELOID LEUKEMIA AND IDENTIFY A BLAST-PHASE-LIKE SUBGROUP

EHA Library, Xiaoshuai Zhang, 4206713

HMGA1 STABILIZES MYC PROTEIN TO DRIVE ONCOGENIC TRANSCRIPTIONAL PROGRAMS IN TRANSFORMED FOLLICULAR LYMPHOMA (FL)

EHA Library, Androniki Michaelou, 4206808

EFFICACY AND SAFETY OF LUSPATERCEPT IN PATIENTS WITH MYELOFIBROSIS ON JANUS KINASE INHIBITORS WHO REQUIRE RED BLOOD CELL TRANSFUSIONS: PRIMARY ANALYSIS OF THE PHASE 3 INDEPENDENCE TRIAL

EHA Library, Francesco Passamonti, 4206769

IMPROVING EFFICACY AND SAFETY OUTCOMES IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN MORPHOLOGIC REMISSION TREATED WITH OBECABTAGENE AUTOLEUCEL (OBE-CEL)

EHA Library, Claire Roddie, 4206667

CD5 INHIBITION AS A GENERALIZABLE STRATEGY TO AMPLIFY T CELL-MEDIATED ANTI-TUMOR EFFECTS OF BISPECIFIC T-CELL ENGAGERS

EHA Library, Weilin Wang, 4206658

NANOLEUKEMIA - A HIERARCHICAL CLASSIFICATION FRAMEWORK FOR HEMATOPOIETIC NEOPLASMS INTEGRATING EPIGENETIC AND GENETIC INFORMATION FROM WHOLE GENOME NANOPORE SEQUENCING

EHA Library, Maximilian Schönung, 4206887

HEAVY MENSTRUAL BLEEDING IN MILD-TO-MODERATE BLEEDING DISORDERS: INVESTIGATING PREVALENCE AND RISK-FACTORS USING MACHINE LEARNING

EHA Library, Tim Dreier, 4206876

ETAVOPIVAT IMPROVES HEMOGLOBIN LEVELS IN ADULTS AND ADOLESCENTS WITH NON-TRANSFUSION-DEPENDENT ALPHA- OR ΒETA-THALASSEMIA: RESULTS FROM THE OPEN-LABEL PHASE 2 GLADIOLUS STUDY

EHA Library, Sujit Sheth, 4206851

MAJESTEC-9: A PHASE 3 STUDY OF TECLISTAMAB MONOTHERAPY VS POMALIDOMIDE/BORTEZOMIB/DEXAMETHASONE OR CARFILZOMIB/DEXAMETHASONE (PVD/KD) IN PATIENTS (PTS) WITH RELAPSED REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Cyrille Touzeau, 4206749

TARGETING MYELOID IMMUNE CHECKPOINTS TO ENHANCE ANTI-MULTIPLE MYELOMA IMMUNITY

EHA Library, Marcello Turi, 4206745

LILRB4 DRIVES IMMUNOSUPPRESSIVE MYELOID CELL FORMATION VIA THE S100A4-CCL3 AXIS TO PROMOTE IMMUNE EVASION IN MULTIPLE MYELOMA

EHA Library, Mu Hao, 4206746

TARGETING THE ATYPICAL PROTEIN KINASE WNK1 IN TAL1-RELATED T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Giovanni Roti, 4206659

SAFETY AND EFFICACY OF ELRANATAMAB AS EARLY INTERVENTION IN PATIENTS WITH HIGH-RISK SMOLDERING MYELOMA: FIRST RESULTS FROM THE PHASE 2 ERASMM (EMN34) STUDY

EHA Library, Cyrille Touzeau, 4206759

AGGRESSIVE SMOLDERING CURATIVE APPROACH EVALUATING NOVEL THERAPIES (ASCENT): A PHASE 2 TRIAL OF INDUCTION, CONSOLIDATION, AND MAINTENANCE IN HIGH-RISK SMOLDERING MULTIPLE MYELOMA

EHA Library, Shaji Kumar, 4206761

PHASE 1 DOSE ESCALATION SAFETY AND EFFICACY OF ETENTAMIG IN PATIENTS WITH RELAPSED OR REFRACTORY LIGHT CHAIN AMYLOIDOSIS

EHA Library, Efstathios Kastritis, 4206763

COFORMULATED FAVEZELIMAB/PEMBROLIZUMAB VERSUS CHEMOTHERAPY IN PARTICIPANTS WITH RELAPSED OR REFRACTORY CLASSIC HODGKIN LYMPHOMA: RESULTS OF THE RANDOMIZED PHASE 2 KEYFORM-008 STUDY

EHA Library, Guilherme Perini, 4206774

FINAL ANALYSIS OF THE GHSG HD21 OLDER COHORT: EFFICACY, SURVIVAL AND LATE TOXICITY OF PET-GUIDED BRECADD IN OLDER PATIENTS WITH ADVANCED-STAGE CLASSIC HODGKIN LYMPHOMA

EHA Library, Justin Ferdinandus, 4206775

NOTCHING UP LEUKEMIA-INITIATING CELLS TO ERADICATE T-ALL

EHA Library, Guillaume Andrieu, 4206662

ASSESSMENT OF NIPOCALIMAB EFFECTS ON FATIGUE IN WARM AUTOIMMUNE HEMOLYTIC ANEMIA: RESULTS FROM THE DOUBLE-BLIND PHASE 2/3 ENERGY TRIAL

EHA Library, Irina Murakhovskaya, 4206879

SAFETY DATA AND INITIAL POOLED EFFICACY DATA FROM THE NORDIC LYMPHOMA GROUP PHASE 3 POLAR BEAR TRIAL IN ELDERLY OR FRAIL PATIENTS WITH DIFFUSE LARGE CELL LYMPHOMA - R-POLA-MINI-CHP VS. R-MINI-CHOP

EHA Library, Mats Jerkeman, 4206792

GOLCADOMIDE (GOLCA), A POTENTIAL, FIRST-IN-CLASS ORAL CELMOD + POLA-RCHP IN PATIENTS (PTS) WITH NEWLY DIAGNOSED AGGRESSIVE B-CELL LYMPHOMA (A-BCL): SAFETY AND 12-MONTH EFFICACY FROM A PHASE 1B STUDY

EHA Library, Maria Bouzani, 4206793

EARLY T-CELL RECEPTOR REPERTOIRE FEATURES PREDICT LONG-TERM OUTCOME IN PAEDIATRIC IMMUNE THROMBOCYTOPAENIA

EHA Library, Amna Malik, 4206873

PHASE 3 LUNA3 FINAL EFFICACY AND SAFETY RESULTS FOR RILZABRUTINIB IN THE LONG-TERM EXTENSION PERIOD IN ADULTS WITH PERSISTENT/CHRONIC IMMUNE THROMBOCYTOPENIA (ITP)

EHA Library, David J. Kuter, 4206869

BEYOND PATIENT FACTORS: THE SUBSTANTIAL IMPACT OF SURGEON AND PROCEDURE VARIABILITY ON BLOOD TRANSFUSION RISK

EHA Library, Esa Turkulainen, 4206863

TITLE: RALLY-MF: INITIAL EFFICACY OF A PHASE 2 STUDY OF DISC-0974, AN ANTI-HEMOJUVELIN ANTIBODY, TO TREAT ANEMIA IN MYELOFIBROSIS

EHA Library, Naseema Gangat, 4206860

DIGITAL CAPABILITIES AND TRANSFUSION PRACTICE IN EUROPEAN HOSPITALS: EMERGING FINDINGS FROM THE PAN-EUROPEANTRANSFUSION RESEARCH INFRASTRUCTURE (PETRA) COLLABORATIVE

EHA Library, Hayley G Evans, 4206861

THE COOL SIDE OF PLATELETS: EMERGENCE OF UNIQUE PLATELET SUBPOPULATIONS WITH SPECIFIC FUNCTIONAL PROPERTIES IN COLD-STORED PLATELET CONCENTRATES

EHA Library, Xavier Delabranche, 4206862

TIME TO PLATELET COUNT RESPONSE AFTER INTRAVENOUS EFGARTIGIMOD IN ADULTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA IN A PHASE 3 CLINICAL TRIAL (ADVANCE IV) AND ITS OPEN-LABEL EXTENSION STUDY (ADVANCE IV+)

EHA Library, Monica Carpenedo, 4206870

IMPACT OF PROTOCOL‑MANDATED DOSE HOLDS ON PLATELET RESPONSE DURABILITY IN PEDIATRIC ITP PATIENTS TREATED WITH AVATROMBOPAG: AVA‑301 POST‑HOC ANALYSIS

EHA Library, Amanda Grimes, 4206872

PAIRED PROTEOMIC ANALYSIS OF IN VIVO AND EX VIVO HUMAN ERYTHROID DIFFERENTIATION IDENTIFIES KEY ELEMENTS OF STRESS ERYTHROPOIESIS

EHA Library, Pedro Moura, 4206859

MAPPING RESEARCH AND EQUITY ACROSS EUROPE: FINDINGS FROM THE EUROPEAN ATLAS ON CLINICAL TRIALS IN CANCER AND HAEMATOLOGY (EUROACT)

EHA Library, Lis Puga, 4206880

PROGNOSTIC IMPORTANCE OF PRE-TREATMENT HEALTH-RELATED QUALITY OF LIFE AND FITNESS INDICATORS IN OLDER ADULTS WITH ACUTE MYELOID LEUKEMIA. ANALYSIS FROM THE INTERNATIONAL EORTC AML 21 PHASE 3 TRIAL

EHA Library, Fabio Efficace, 4206881

HEALTH-RELATED QUALITY OF LIFE FOR LONG-TERM SURVIVORS OF CLASSICAL HODGKIN LYMPHOMA WITH AND WITHOUT RELAPSE

EHA Library, Joachim Baech, 4206882

COST-EFFECTIVENESS AND BUDGET IMPACT OF GENE THERAPY FOR ELIGIBLE PATIENTS WITH SICKLE CELL DISEASE IN THE NETHERLANDS

EHA Library, Melanie Bruinooge, 4206883

TARGETING PCYT1A INDUCES SYNTHETIC LETHALITY IN MONOCYTIC AML BY TRIGGERING PEMT-DEPENDENT METABOLIC CATASTROPHE AND ONE-CARBON IMBALANCE

EHA Library, Jakushin Nakahara, 4206671

LUSPATERCEPT (LUSPA) INITIATED AT THE MAXIMUM-APPROVED DOSE IN PATIENTS (PTS) WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) WHO REQUIRE TRANSFUSIONS: PRIMARY ANALYSIS FROM MAXILUS

EHA Library, Matteo Giovanni Della Porta, 4206727

ONCOGENIC MECHANISMS AND THERAPEUTIC TARGETING OF THE HIGH-RISK CDX2/UBTF B-ALL

EHA Library, Hugo Bergugnat, 4206660

ECTOPIC ACTIVATION OF FOXF1 AND FENDRR BY T(14;16)(Q32;Q24) IDENTIFIES A HIGH-RISK T-ALL/MPAL SUBTYPE.

EHA Library, Danika Di Giacomo, 4206661

TUNING AND TARGETING CCR9 FOR THE TREATMENT OF T-ALL

EHA Library, Jamie Deyell, 4206663

CPX-351 VERSUS STANDARD OF CARE AS BRIDGING TO ALLOHCT IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC NEOPLASMS OR OLIGOBLASTIC ACUTE MYELOID LEUKEMIA: RESULTS OF THE RANDOMIZED PHASE 2 PALOMA STUDY

EHA Library, Uwe Platzbecker, 4206724

EPIGENETIC-METABOLIC REPROGRAMMING OF MACROPHAGES BY DECITABINE REMODELS THE POST-TRANSPLANT IMMUNE MICROENVIRONMENT TO PREVENT AML RELAPSE VIA THE H3K4ME3-ACOD1-ITACONATE AXIS

EHA Library, Yutong Xie, 4206669

NPM1C REQUIRES SNORNA DEPENDENT CHROMATIN BINDING FOR LEUKEMOGENESIS

EHA Library, Fengbiao Zhou, 4206670

ZEB1 DEFINES A TARGETABLE MENIN-INHIBITOR ESCAPE PROGRAM IN KMT2A::MLLT3 AML

EHA Library, Liam MacPhee, 4206672

ERG RECONFIGURES A CONTEXT-SPECIFIC LEUKAEMIC 3D ENHANCER LANDSCAPE TO DRIVE AML VIA DIRECT ENHANCER-MACHINERY REPURPOSING AND INDIRECT TRANSCRIPTION FACTOR BLOCKADE

EHA Library, Cécile Lopez, 4206673

FIRST-LINE TREATMENT OF CLL/SLL WITH THE ALL-ORAL COMBINATION OF SONROTOCLAX AND ZANUBRUTINIB ACHIEVES UNDETECTABLE MINIMAL RESIDUAL DISEASE RATES OF >90%, INCLUDING IN PATIENTS WITH DEL(17P)/TP53

EHA Library, Chan Y. Cheah, 4206699

OXPLORED: A MULTICENTRE UK-WIDE OBSERVATIONAL STUDY TO IDENTIFY AND PROSPECTIVELY VALIDATE PREDICTORS OF DISEASE PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) AND MBL

EHA Library, Danmei Xu, 4206701

VENETOCLAX-OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: FINAL RESULTS OF THE RANDOMIZED CLL14 STUDY

EHA Library, Kirsten Fischer, 4206700

EARLY VERSUS DELAYED ESA IN LOWER-RISK NON -TRANSFUSION-DEPENDENT MDS: FINAL PHASE III EPO-PRETAR RESULTS ON TRANSFUSION DEPENDENCE AND ERYTHROID RESPONSE

EHA Library, Sophie Park, 4206725

FUNCTIONAL TP53 PHENOTYPE SCORE REFINES PROGNOSTIC STRATIFICATION IN MONOALLELIC TP53-MUTATED MYELODYSPLASTIC NEOPLASMS BEYOND ALLELIC STATE

EHA Library, Alexander Streuer, 4206726

OFIRNOFLAST, A FIRST-IN-CLASS NEK7 INHIBITOR, INDUCES ROBUST TRANSFUSION INDEPENDENCE AND MULTILINEAGE HEMATOLOGICAL IMPROVEMENT IN LOWER-RISK MYELODYSPLASTIC SYNDROME(LR-MDS): PHASE 2 RESULTS

EHA Library, VARUN BAFNA, 4206728

A PHASE 2 STUDY OF FIXED-DURATION PIRTOBRUTINIB AND OBINUTUZUMAB IN PREVIOUSLY UNTREATED CLL

EHA Library, Inhye E. Ahn, 4206702

GENETIC BIOMARKERS PREDICTING SUSTAINED EFFICACY OF VENETOCLAX-BASED THERAPIES OR CIT IN CHRONIC LYMPHOCYTIC LEUKEMIA: FINAL 5‑YEAR ANALYSIS OF THE GAIA/CLL13 TRIAL

EHA Library, Eugen Tausch, 4206703

POLATUZUMAB VEDOTIN PLUS RITUXIMAB, IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE (POLA-R-ICE) VS R-ICE AS SECOND LINE TREATMENT IN LARGE B CELL LYMPHOMA (LBCL). FINAL ANALYSIS OF A RANDOMIZED PHASE 3 STUDY

EHA Library, Bertram Glass, 4206791

VISPA-CEL, AN ALLOGENEIC ANTI-CD19 CAR-T CELL THERAPY WITH A PD-1 KNOCKOUT, IN PATIENTS WITH RELAPSED/REFRACTORY B CELL NON-HODGKIN LYMPHOMA (ANTLER PHASE 1 CLINICAL TRIAL)

EHA Library, Stephen Schuster, 4206790

CIRCULATING TUMOR DNA COMPLEMENTS BONE MARROW GENOTYPING AND TRACKS MRD KINETICS IN MULTIPLE MYELOMA: RESULTS FROM A DSMM XVII COHORT

EHA Library, Philipp Nakov, 4206744

VIRMA EPITRANSCRIPTOMICALLY REGULATES CELL PROLIFERATION, APOPTOSIS, AND MITOCHONDRIAL FUNCTION VIA M6A IN MULTIPLE MYELOMA

EHA Library, Estibaliz Urizar-Compains, 4206747

INTEGRATED PHENOTYPIC CLASSIFICATION OF MULTIPLE MYELOMA USING MULTIMODAL SPATIAL TUMOR BURDEN AND SOLUBLE BCMA: REFINING R-ISS AND CHARACTERIZING BIOLOGICAL DISCORDANCE

EHA Library, Masanori Toho, 4206748

PHASE 3 RANDOMIZED TRIAL OF ANSELAMIMAB DEMONSTRATES IMPROVEMENT IN ALL-CAUSE MORTALITY IN Κ LIGHT-CHAIN AMYLOIDOSIS

EHA Library, Ashutosh Wechalekar, 4206760

INITIAL EFFICACY AND SAFETY DATA FROM THE PHASE 1/2 LINKER-AL2 STUDY OF LINVOSELTAMAB (LINVO) MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY (RR) SYSTEMIC LIGHT CHAIN (AL) AMYLOIDOSIS

EHA Library, Ashutosh Wechalekar, 4206762

DEVELOPMENT OF A G6B DIRECTED ANTIBODY DRUG CONJUGATE FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Adam Mead, 4206764

ONCOGENIC RAS EXPLOITS A FETAL-RESTRICTED CHROMATIN STATE TO INITIATE JMML VIA CEBPB ACTIVATION

EHA Library, Giulia Orlando, 4206765

CD9 MARKS THE DISEASE-PROPAGATING HEMATOPOIETIC STEM CELL POPULATION IN MYELOFIBROSIS

EHA Library, Lara Tavernari, 4206767

TRANSCRIPTIONAL SUBTYPES OF MYELOFIBROSIS ARE INDEPENDENT OF DRIVER MUTATIONS AND CAPTURE DISTINCT BIOLOGY, OUTCOMES, AND DISEASE TRAJECTORIES

EHA Library, Andy Zeng, 4206768

RESULTS FROM EPCORE DLBCL-1: RANDOMIZED PHASE 3 STUDY OF EPCORITAMAB (EPCOR) VS INVESTIGATOR’S CHOICE CHEMOIMMUNOTHERAPY (CIT) IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (R/R LBCL)

EHA Library, Christopher P. Fox, 4206789

AVELUMAB IN THE FRONT-LINE TREATMENT OF ADVANCED CLASSICAL HODGKIN LYMPHOMA (AVENUE)- FINAL 3-YEAR RESULTS OF PHASE II STUDY

EHA Library, Aisling Barrett, 4206776

INTERIM PET/CT ADAPTED PD-1 INHIBITOR INCORPORATION TO AVOID HIGH-DOSE CHEMOTHERAPY AND RADIOTHERAPY IN CLASSICAL HODGKIN’S LYMPHOMA

EHA Library, Shenmiao Yang, 4206777

ULTRASENSITIVE CTDNA MRD BY PHASED-SEQ COMPLEMENTS PET/CT AND PREDICTS TREATMENT FAILURE IN EARLY AND ADVANCED CLASSIC HODGKIN LYMPHOMA

EHA Library, Jan Lukas Boegeholz, 4206778

REAL-WORLD DATA ON DOAC USE IN CHILDREN: AN UPDATE FROM THE INTERNATIONAL THROM-PED DOAC REGISTRY

EHA Library, Susanne Holzhauer, 4214965

GOLCADOMIDE (GOLCA), A POTENTIAL, FIRST-IN-CLASS, ORAL CELMOD ±RITUXIMAB (R) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA (FL): PHASE (PH) 1/2 STUDY LONG-TERM FOLLOW-UP (F/U)

EHA Library, Daniel Morillo, 4206781

SUROVATAMIG (AZD0486) PLUS RITUXIMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (FL): INITIAL SAFETY DATA FROM THE PHASE 3 SOUNDTRACK-F1 TRIAL

EHA Library, Chan Y. Cheah, 4206782

ENABLE: UPDATED EFFICACY AND SAFETY RESULTS OF ELVN-001, A NOVEL SELECTIVE ATP-COMPETITIVE INHIBITOR OF BCR::ABL1, IN PATIENTS WITH PREVIOUSLY TREATED CP-CML

EHA Library, Dennis Kim, 4206718

THE DYNAMIC LANDSCAPE OF IMMUNE ENVIRONMENT FOR MM PATIENTS RECEIVING T CELL REDIRECTING THERAPIES

EHA Library, Haimeng Li, 4206740

SUCCESSFUL IN VIVO CAR-T GENERATION AND MINIMAL RESIDUAL DISEASE (MRD) CLEARANCE WITH KLN-1010 ACROSS DIVERSE BASELINE T CELL PHENOTYPES IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM)

EHA Library, Andrew Spencer, 4206739

HIGH RATES OF SUCCESSFUL SECOND STOP ATTEMPTS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: RESULTS OF THE NAUT TRIAL

EHA Library, Katharina Kohlbrenner, 4206716

SAFETY AND EFFICACY OF SUBCUTANEOUS MOSUNETUZUMAB PLUS LENALIDOMIDE INDUCTION THERAPY FOLLOWED BY MOSUNETUZUMAB MAINTENANCE IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA

EHA Library, Emmanuel Bachy, 4206780

DISTINCT IMMUNE DIVERSITY OF CD8+ T CELLS DEFINES PEDIATRIC HEPATITIS-ASSOCIATED APLASTIC ANEMIA AND SEVERE APLASTIC ANEMIA

EHA Library, Lixian Chang, 4206731

A TIME-RESOLVED SINGLE‑NUCLEUS MULTIOME ATLAS OF HUMAN FETAL LIVER HEMATOPOIESIS

EHA Library, Yiwei Niu, 4206830

MITOCHONDRIAL DNA MOSAICISM AND CLONALITY IN HUMAN HEMATOPOIETIC AGING AND REGENERATION

EHA Library, Ambre Giguelay, 4206832

MAPPING HEMATOPOIETIC STEM CELL NICHE INTERACTIONS AT SINGLE-CELL AND CLONAL RESOLUTION IDENTIFIES ALTERED CROSSTALK AND NOVEL TARGETS: Β-THALASSEMIA AS A CASE STUDY OF INHERITED BLOOD DISORDERS

EHA Library, Annamaria Aprile, 4206833

PONATINIB CONSOLIDATION AND DISCONTINUATION IN CML PATIENTS AFTER FAILED FIRST TFR ATTEMPT: UPDATED TFR OUTCOMES AND CHIP MUTATION ANALYSIS FROM THE RESTOP TRIAL

EHA Library, Gonzalo Carreño Gómez-Tarragona, 4206715

LONG-TERM OUTCOMES IN PATIENTS WITH RELAPSED OR REFRACTORY SEVERE APLASTIC ANEMIA

EHA Library, Fieke Hoff, 4206732

NIPOCALIMAB FOR WARM AUTOIMMUNE HEMOLYTIC ANEMIA: RESULTS FROM THE PHASE 2/3 RANDOMIZED DOUBLE-BLIND ENERGY STUDY

EHA Library, Bruno Fattizzo, 4206854

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY OF ESLIM-02 FOR EFFICACY AND SAFETY OF SOVLEPLENIB (HMPL-523) IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA IN CHINA

EHA Library, Bing Han, 4206855

AZD0120, A DUAL BCMA/CD19 CAR-T CELL THERAPY, DEMONSTRATES A NAIVE/CENTRAL MEMORY PHENOTYPE AND INDUCES A RAPID DECLINE IN SOLUBLE BCMA IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

EHA Library, Binod Dhakal, 4206741

REAL-WORLD EXPERIENCE OF MITAPIVAT IN PYRUVATE KINASE DEFICIENCY

EHA Library, Giacinto Luca Pedone, 4206856

DEVELOPMENT OF BMS-986453, A DUAL-TARGETING BCMA×GPRC5D CHIMERIC ANTIGEN RECEPTOR (CAR) FOR THE TREATMENT OF MULTIPLE MYELOMA

EHA Library, Doris Hansen, 4206742

THE LANDSCAPE OF SOMATIC RETROTRANSPOSON MUTATIONS IN HSCS, AND A NOVEL JAK2 SIGNALLING PATHWAY TO HNRNPA1 THAT REPRESSES RETROTRANSPOSON ACTIVITY

EHA Library, Stephen Loughran, 4206831

ULTRA-SENSITIVE METABOLOMICS UNCOVERS L-CARNITINE AS A CRITICAL REGULATOR OF HUMAN HEMATOPOIETIC STEM CELL REGENERATION

EHA Library, Honglin Duan, 4206829

CLINICALLY RELEVANT SUBGROUP ANALYSIS FROM THE RANDOMIZED PHASE 3 EPCORE FL-1 TRIAL: TREATMENT (TX) EFFECT OF EPCORITAMAB WITH LENALIDOMIDE AND RITUXIMAB (R²) IN R/R FOLLICULAR LYMPHOMA (FL)

EHA Library, Benoit Tessoulin, 4206783

MOSUNETUZUMAB FOR EARLY RELAPSE OF FOLLICULAR LYMPHOMA IN THE NORDIC COUNTRIES (MERLIN, NLG-FL6/ML43841)

EHA Library, Marianne Brodtkorb, 4206779

BTL-101, A FULLY HUMAN TRISPECIFIC BCMA×GPRC5D×CD3 T-CELL ENGAGER FOR THE TREATMENT OF MULTIPLE MYELOMA

EHA Library, Jiansong Yang, 4206743

EARLY BONE FRAGILITY IS ASSOCIATED WITH VASCULAR ABNORMALITIES IN TELOMERE BIOLOGY DISORDERS: FINDINGS FROM THE MULTICENTER, INTERNATIONAL INSIGHT STUDY

EHA Library, Jane Koo, 4206733